Less than half the price of your US generic.
Information about Treanda (Bendamustine)
Treanda is a chemotherapy medication containing the active ingredient bendamustine. It is used to treat certain types of cancer, including chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Bendamustine is an alkylating agent, which works by interfering with the DNA in cancer cells, preventing them from dividing and growing.
Product Highlights
- Chronic Lymphocytic Leukemia (CLL): Treanda is used to treat CLL, a type of cancer that affects white blood cells.
- Non-Hodgkin Lymphoma (NHL): It is used for treating certain types of NHL, including follicular lymphoma and other B-cell lymphomas.
- Other Off-Label Uses: Treanda may also be used in other cancers or as part of combination chemotherapy regimens, as determined by a healthcare provider.
Key Ingredient:
Key Benefits
- Effective Against Cancers: Treanda is effective in treating specific blood cancers, including chronic lymphocytic leukemia and non-Hodgkin lymphoma, by targeting and destroying cancer cells.
- Combination Therapy: It can be used as part of combination regimens with other chemotherapy agents, potentially improving treatment outcomes.
- Multiple Administration Routes: Bendamustine can be given as an IV infusion or, in some cases, as an oral form (for specific indications), offering flexibility in treatment options.
Direction of Use
- IV Infusion: Treanda is typically administered as an IV infusion in a healthcare setting. The exact dosage and frequency depend on the type of cancer being treated and the patient's health condition.
- Oral Tablets (for CLL): For chronic lymphocytic leukemia, the oral form of Treanda may be prescribed in certain cases. It should be taken exactly as directed by the healthcare provider.
- Monitoring: Patients receiving Treanda must be closely monitored for side effects and effectiveness, with regular blood tests and assessments to adjust treatment as necessary.
Safety Concerns
- Bone Marrow Suppression: Treanda can cause a decrease in blood cell production, leading to conditions like anemia, neutropenia (low white blood cell count), and thrombocytopenia (low platelet count). Blood counts should be monitored regularly.
- Infections: Due to its effect on the immune system, Treanda can increase the risk of infections. Patients should be vigilant for signs of infection and seek immediate medical attention if symptoms arise.
- Nausea and Vomiting: Chemotherapy treatments like Treanda can cause nausea and vomiting, which may require supportive care and antiemetic medications.
- Fatigue and Weakness: Many patients experience fatigue and weakness during treatment, which may be due to the chemotherapy’s effect on the body.
- Allergic Reactions: Severe allergic reactions, such as difficulty breathing, swelling, or rash, may occur. Immediate medical attention is needed in the case of an allergic response.
- Liver and Kidney Function: Treanda may affect liver and kidney function, so regular monitoring of liver enzymes and kidney function is necessary during treatment.
Avoid Treanda (Bendamustine) If
- Allergic to Bendamustine or Similar Medications: Avoid Treanda if you have a known allergy to bendamustine or any of its ingredients.
- Severe Bone Marrow Suppression: Patients with severe bone marrow suppression or very low blood cell counts should not use Treanda.
- Active Infections: Patients with active infections should not begin treatment with Treanda until the infection is resolved.
- Pregnancy and Breastfeeding: Treanda should not be used during pregnancy due to potential harm to the fetus. It should also be avoided during breastfeeding, as it can pass into breast milk.
- Severe Liver or Kidney Impairment: Treanda should be used with caution or avoided in patients with severe liver or kidney impairment, as it can affect the organs' function.
- History of Heart Problems: Patients with certain heart conditions should be carefully monitored, as chemotherapy drugs like Treanda may have cardiovascular effects.
